BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Meiji Seika Kaisha, Ltd. 

4-16-1, Hatchobori

Chuo-Ku  Tokyo  104-8002  Japan
Phone: 81-3-3272-6511 Fax: 81-3-3271-3528


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Celentyx Enters Into Agreement With Meiji Seika Kaisha, Ltd. To Discover New Development Paths For Meiji Drug Candidates Using Celentyx's Novel Clinical Indication Profiling(TM) 8/24/2009 11:54:55 AM
Amalyte and Meiji Seika Kaisha, Ltd. Enter Into a License, Development and Commercialization Agreement on AM3301 and a Novel Class of Anti-Inflammatory Compounds 6/8/2009 9:48:28 AM
ACADIA Pharmaceuticals, Inc. (ACAD) And Meiji Seika Kaisha, Ltd. Form Collaboration to Develop and Commercialize a New Class of Pro-Cognitive Schizophrenia Drugs 3/25/2009 10:18:42 AM
Symphogen A/S and Meiji Seika Kaisha, Ltd. Achieve Milestone in Discovery Collaboration for Recombinant Polyclonal Antibody, Sym006 12/4/2008 10:21:24 AM
Symphogen A/S And Meiji Seika Kaisha, Ltd. Enter Agreement For Recombinant Polyclonal Antibody Product 12/11/2006 12:50:10 PM
Cerexa, Inc. Expands Portfolio Of Novel Anti-Infective Therapies Through In-Licensing Agreement With Meiji Seika Kaisha, Ltd. 11/1/2006 12:24:23 PM
MediciNova, Inc. Announces The Acquisition Of Two Novel Antithrombotic Agents From Meiji Seika Kaisha, Ltd. 11/1/2006 11:18:37 AM
Meiji Seika Kaisha, Ltd. And Solvay Seiyaku Obtain Additional Approval For Fluvoxamine Maleate10/19/2005 5:13:22 PM
Nippon Organon KK Licenses Antidepressant To Meiji Seika Kaisha, Ltd.10/19/2005 5:11:19 PM
Meiji Seika Kaisha, Ltd. Subsidiary Receives Sales Approval For "MEIACT" In Spain10/19/2005 5:11:05 PM
12